Concepts (332)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain | 34 | 2019 | 809 | 3.720 |
Why?
|
Magnetic Resonance Imaging | 29 | 2019 | 1144 | 3.160 |
Why?
|
Brain Mapping | 9 | 2018 | 134 | 3.040 |
Why?
|
Brain Concussion | 7 | 2019 | 56 | 1.520 |
Why?
|
Brain Diseases | 6 | 2018 | 39 | 1.420 |
Why?
|
Image Interpretation, Computer-Assisted | 7 | 2018 | 111 | 1.320 |
Why?
|
Football | 9 | 2019 | 69 | 1.240 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2017 | 229 | 1.220 |
Why?
|
Spinal Fractures | 4 | 2012 | 38 | 1.110 |
Why?
|
Algorithms | 5 | 2017 | 456 | 1.040 |
Why?
|
Marijuana Abuse | 2 | 2019 | 16 | 0.970 |
Why?
|
Diabetes Mellitus, Type 2 | 12 | 2018 | 1556 | 0.950 |
Why?
|
Decision Making | 2 | 2019 | 154 | 0.860 |
Why?
|
Nerve Net | 2 | 2014 | 88 | 0.830 |
Why?
|
Reward | 2 | 2019 | 17 | 0.730 |
Why?
|
Humans | 65 | 2019 | 28304 | 0.710 |
Why?
|
Sacrum | 3 | 2009 | 21 | 0.710 |
Why?
|
Male | 52 | 2019 | 16967 | 0.710 |
Why?
|
Cognition Disorders | 8 | 2018 | 388 | 0.690 |
Why?
|
Image Enhancement | 6 | 2014 | 70 | 0.670 |
Why?
|
Rest | 2 | 2017 | 47 | 0.640 |
Why?
|
Cognition | 8 | 2018 | 512 | 0.640 |
Why?
|
Atlases as Topic | 1 | 2016 | 7 | 0.570 |
Why?
|
Adolescent | 20 | 2019 | 3184 | 0.570 |
Why?
|
Magnetoencephalography | 2 | 2014 | 6 | 0.530 |
Why?
|
Female | 39 | 2019 | 17679 | 0.520 |
Why?
|
Craniocerebral Trauma | 4 | 2019 | 51 | 0.520 |
Why?
|
African Americans | 9 | 2018 | 1513 | 0.510 |
Why?
|
Cerebrum | 1 | 2014 | 6 | 0.500 |
Why?
|
Tomography, X-Ray Computed | 10 | 2015 | 858 | 0.490 |
Why?
|
Cerebrovascular Disorders | 3 | 2013 | 45 | 0.450 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 3 | 2019 | 27 | 0.440 |
Why?
|
Disease Models, Animal | 3 | 2019 | 915 | 0.430 |
Why?
|
Bone Cements | 2 | 2012 | 10 | 0.420 |
Why?
|
Polymethyl Methacrylate | 2 | 2012 | 11 | 0.420 |
Why?
|
Spin Labels | 7 | 2017 | 25 | 0.400 |
Why?
|
Glucose | 5 | 2003 | 163 | 0.390 |
Why?
|
Models, Neurological | 1 | 2011 | 63 | 0.390 |
Why?
|
Athletes | 4 | 2019 | 62 | 0.380 |
Why?
|
Cerebrovascular Circulation | 5 | 2017 | 90 | 0.370 |
Why?
|
Brain Injuries | 3 | 2015 | 85 | 0.370 |
Why?
|
Head Injuries, Closed | 3 | 2019 | 17 | 0.360 |
Why?
|
Vitronectin | 1 | 2008 | 3 | 0.340 |
Why?
|
Drug Implants | 1 | 2008 | 8 | 0.340 |
Why?
|
Adult | 18 | 2019 | 8243 | 0.340 |
Why?
|
Animals | 16 | 2019 | 6402 | 0.340 |
Why?
|
Alzheimer Disease | 3 | 2018 | 291 | 0.330 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 42 | 0.330 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2017 | 272 | 0.320 |
Why?
|
Emotions | 2 | 2018 | 43 | 0.310 |
Why?
|
Laminectomy | 1 | 2007 | 10 | 0.310 |
Why?
|
Child | 15 | 2019 | 2151 | 0.310 |
Why?
|
Back Pain | 1 | 2007 | 26 | 0.310 |
Why?
|
Models, Biological | 2 | 2019 | 356 | 0.300 |
Why?
|
Magnetic Resonance Angiography | 3 | 2013 | 59 | 0.300 |
Why?
|
Mutation | 3 | 2019 | 451 | 0.290 |
Why?
|
Young Adult | 10 | 2019 | 2321 | 0.290 |
Why?
|
Neuropsychological Tests | 8 | 2018 | 370 | 0.290 |
Why?
|
Middle Aged | 22 | 2019 | 10678 | 0.290 |
Why?
|
Head Protective Devices | 5 | 2018 | 45 | 0.280 |
Why?
|
Aged | 18 | 2019 | 9256 | 0.270 |
Why?
|
Telemetry | 4 | 2018 | 27 | 0.260 |
Why?
|
Nerve Fibers, Myelinated | 3 | 2016 | 31 | 0.260 |
Why?
|
Gambling | 1 | 2004 | 6 | 0.260 |
Why?
|
Hippocampus | 2 | 2018 | 135 | 0.250 |
Why?
|
Temporal Bone | 2 | 2013 | 17 | 0.240 |
Why?
|
Finite Element Analysis | 2 | 2019 | 80 | 0.240 |
Why?
|
Hearing Loss, Sensorineural | 2 | 2013 | 20 | 0.240 |
Why?
|
Rats | 9 | 2018 | 1425 | 0.230 |
Why?
|
Sex Characteristics | 2 | 2014 | 158 | 0.230 |
Why?
|
Sensitivity and Specificity | 5 | 2018 | 521 | 0.230 |
Why?
|
Acceleration | 3 | 2018 | 59 | 0.230 |
Why?
|
Rats, Sprague-Dawley | 7 | 2008 | 624 | 0.220 |
Why?
|
Albuminuria | 4 | 2017 | 207 | 0.210 |
Why?
|
Aged, 80 and over | 8 | 2014 | 3562 | 0.200 |
Why?
|
Analysis of Variance | 4 | 2013 | 390 | 0.200 |
Why?
|
Atrophy | 3 | 2016 | 51 | 0.200 |
Why?
|
Prefrontal Cortex | 2 | 2018 | 33 | 0.200 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2017 | 80 | 0.190 |
Why?
|
Diabetes Complications | 3 | 2018 | 184 | 0.180 |
Why?
|
Organ Size | 5 | 2018 | 204 | 0.180 |
Why?
|
Treatment Outcome | 4 | 2017 | 2886 | 0.180 |
Why?
|
Seasons | 2 | 2018 | 81 | 0.180 |
Why?
|
Positron-Emission Tomography | 3 | 2019 | 134 | 0.180 |
Why?
|
Hemiplegia | 1 | 2019 | 11 | 0.180 |
Why?
|
Retrospective Studies | 9 | 2018 | 2930 | 0.180 |
Why?
|
European Continental Ancestry Group | 4 | 2018 | 1203 | 0.180 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 6 | 0.180 |
Why?
|
Stress, Psychological | 2 | 2018 | 184 | 0.180 |
Why?
|
Reproducibility of Results | 4 | 2014 | 700 | 0.180 |
Why?
|
Amyloid | 1 | 2019 | 17 | 0.180 |
Why?
|
Magnetic Field Therapy | 1 | 2019 | 16 | 0.180 |
Why?
|
Calcium Channels, T-Type | 1 | 2019 | 18 | 0.180 |
Why?
|
Age of Onset | 1 | 2019 | 98 | 0.180 |
Why?
|
Parkinsonian Disorders | 2 | 2019 | 7 | 0.170 |
Why?
|
Body Weight | 2 | 2018 | 289 | 0.170 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2016 | 52 | 0.170 |
Why?
|
Models, Anatomic | 1 | 2019 | 38 | 0.170 |
Why?
|
Hyperemia | 2 | 2008 | 9 | 0.170 |
Why?
|
Head | 1 | 2018 | 46 | 0.170 |
Why?
|
Thyroid Neoplasms | 1 | 2018 | 28 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 91 | 0.160 |
Why?
|
Electrodes, Implanted | 1 | 2018 | 30 | 0.160 |
Why?
|
Microtubules | 1 | 2018 | 15 | 0.160 |
Why?
|
Mental Recall | 1 | 2018 | 50 | 0.160 |
Why?
|
Dystonic Disorders | 2 | 2016 | 12 | 0.160 |
Why?
|
Memory, Short-Term | 1 | 2018 | 41 | 0.160 |
Why?
|
Psychomotor Performance | 1 | 2018 | 59 | 0.160 |
Why?
|
Neural Pathways | 2 | 2016 | 56 | 0.160 |
Why?
|
Glomerular Filtration Rate | 5 | 2017 | 307 | 0.160 |
Why?
|
Databases, Factual | 2 | 2018 | 320 | 0.160 |
Why?
|
Athletic Injuries | 1 | 2018 | 72 | 0.160 |
Why?
|
Brain Neoplasms | 3 | 2019 | 471 | 0.160 |
Why?
|
Diffusion Tensor Imaging | 2 | 2016 | 26 | 0.160 |
Why?
|
Calcium | 1 | 2019 | 276 | 0.150 |
Why?
|
Nootropic Agents | 1 | 2017 | 10 | 0.150 |
Why?
|
Students | 1 | 2018 | 159 | 0.150 |
Why?
|
Linear Models | 5 | 2018 | 421 | 0.150 |
Why?
|
Cerebral Arteries | 2 | 2013 | 15 | 0.150 |
Why?
|
Ataxia | 1 | 2016 | 6 | 0.140 |
Why?
|
Apolipoproteins E | 1 | 2016 | 101 | 0.140 |
Why?
|
Ultrasonography | 1 | 2018 | 347 | 0.140 |
Why?
|
Primates | 1 | 2016 | 70 | 0.140 |
Why?
|
Frontal Sinusitis | 1 | 2015 | 5 | 0.130 |
Why?
|
Epidural Abscess | 1 | 2015 | 5 | 0.130 |
Why?
|
Fever | 1 | 2015 | 53 | 0.130 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2013 | 12 | 0.130 |
Why?
|
Skull Fractures | 2 | 2012 | 16 | 0.130 |
Why?
|
Skull | 1 | 2014 | 39 | 0.130 |
Why?
|
Siblings | 1 | 2014 | 24 | 0.130 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2014 | 2 | 0.130 |
Why?
|
Radiology | 1 | 2014 | 37 | 0.120 |
Why?
|
Equipment Design | 2 | 2018 | 161 | 0.120 |
Why?
|
Ear, Inner | 1 | 2013 | 9 | 0.120 |
Why?
|
Apolipoproteins | 1 | 2016 | 217 | 0.120 |
Why?
|
Leukoaraiosis | 1 | 2013 | 2 | 0.120 |
Why?
|
Infant | 6 | 2013 | 928 | 0.120 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 269 | 0.120 |
Why?
|
Ocular Motility Disorders | 1 | 2013 | 5 | 0.120 |
Why?
|
Ear | 1 | 2013 | 18 | 0.120 |
Why?
|
Kidney Diseases | 1 | 2016 | 254 | 0.120 |
Why?
|
Child, Preschool | 6 | 2013 | 1126 | 0.120 |
Why?
|
Pattern Recognition, Automated | 1 | 2013 | 34 | 0.110 |
Why?
|
Body Temperature | 2 | 2003 | 14 | 0.110 |
Why?
|
Quality of Life | 1 | 2018 | 792 | 0.110 |
Why?
|
Hematoma, Subdural | 1 | 2012 | 10 | 0.110 |
Why?
|
Receptors, Drug | 2 | 2003 | 8 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2019 | 655 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 128 | 0.110 |
Why?
|
Calcinosis | 1 | 2013 | 158 | 0.110 |
Why?
|
Fluoroscopy | 1 | 2012 | 37 | 0.110 |
Why?
|
Atherosclerosis | 2 | 2015 | 725 | 0.110 |
Why?
|
Radiography, Interventional | 1 | 2012 | 35 | 0.110 |
Why?
|
Diabetic Nephropathies | 1 | 2014 | 246 | 0.110 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2012 | 51 | 0.110 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 369 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2017 | 1345 | 0.100 |
Why?
|
Accidental Falls | 1 | 2012 | 77 | 0.100 |
Why?
|
Maxillary Sinus | 1 | 2011 | 6 | 0.100 |
Why?
|
Facial Bones | 1 | 2011 | 10 | 0.100 |
Why?
|
Facial Injuries | 1 | 2011 | 13 | 0.100 |
Why?
|
Motor Activity | 2 | 2003 | 251 | 0.100 |
Why?
|
Kidney Function Tests | 3 | 2016 | 108 | 0.100 |
Why?
|
Reference Values | 1 | 2011 | 227 | 0.100 |
Why?
|
Accidents, Traffic | 1 | 2012 | 181 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 22 | 0.090 |
Why?
|
Perfusion Imaging | 1 | 2009 | 7 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 578 | 0.090 |
Why?
|
Tuberous Sclerosis | 1 | 2009 | 6 | 0.090 |
Why?
|
Age Factors | 3 | 2018 | 1058 | 0.090 |
Why?
|
Hypercapnia | 1 | 2008 | 2 | 0.090 |
Why?
|
Coated Materials, Biocompatible | 1 | 2008 | 14 | 0.090 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 42 | 0.090 |
Why?
|
Platinum | 1 | 2008 | 19 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2008 | 87 | 0.080 |
Why?
|
Cohort Studies | 3 | 2018 | 1673 | 0.080 |
Why?
|
Hypoxia, Brain | 1 | 2008 | 4 | 0.080 |
Why?
|
Deoxyglucose | 3 | 2003 | 9 | 0.080 |
Why?
|
Materials Testing | 1 | 2008 | 83 | 0.080 |
Why?
|
Fibrinolytic Agents | 1 | 2008 | 60 | 0.080 |
Why?
|
Epilepsy | 1 | 2009 | 50 | 0.080 |
Why?
|
Radiosurgery | 1 | 2011 | 221 | 0.080 |
Why?
|
Pain Measurement | 2 | 2007 | 328 | 0.080 |
Why?
|
Heterozygote | 2 | 2019 | 54 | 0.080 |
Why?
|
Ethanol | 2 | 1998 | 67 | 0.080 |
Why?
|
Aging | 1 | 2014 | 857 | 0.080 |
Why?
|
Dystonia | 2 | 2019 | 12 | 0.080 |
Why?
|
Carotid Artery Diseases | 1 | 2008 | 114 | 0.080 |
Why?
|
Infusions, Intraosseous | 1 | 2007 | 1 | 0.080 |
Why?
|
Occipital Lobe | 2 | 2017 | 7 | 0.080 |
Why?
|
United States | 4 | 2018 | 3588 | 0.080 |
Why?
|
Pilot Projects | 1 | 2008 | 437 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 498 | 0.080 |
Why?
|
Cadaver | 1 | 2007 | 143 | 0.070 |
Why?
|
Blood Flow Velocity | 3 | 2013 | 59 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2019 | 567 | 0.070 |
Why?
|
Computer Simulation | 1 | 2007 | 187 | 0.070 |
Why?
|
Pyrazoles | 2 | 2003 | 51 | 0.070 |
Why?
|
Diagnostic Imaging | 2 | 2014 | 88 | 0.070 |
Why?
|
Creatinine | 2 | 2017 | 183 | 0.070 |
Why?
|
Piperidines | 2 | 2003 | 84 | 0.070 |
Why?
|
Blood Glucose | 3 | 2015 | 485 | 0.070 |
Why?
|
Depression | 2 | 2018 | 361 | 0.070 |
Why?
|
Time Factors | 4 | 2003 | 1874 | 0.070 |
Why?
|
Time | 1 | 2004 | 16 | 0.060 |
Why?
|
Hypertension | 3 | 2017 | 978 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2002 | 436 | 0.060 |
Why?
|
Radiography | 2 | 2015 | 339 | 0.060 |
Why?
|
Central Nervous System Stimulants | 1 | 2003 | 28 | 0.060 |
Why?
|
Locomotion | 1 | 2003 | 16 | 0.060 |
Why?
|
Head Movements | 2 | 2013 | 10 | 0.060 |
Why?
|
Cocaine | 1 | 2003 | 45 | 0.060 |
Why?
|
Rotation | 2 | 2013 | 44 | 0.060 |
Why?
|
Mice | 2 | 2019 | 2181 | 0.060 |
Why?
|
Carbon Radioisotopes | 2 | 2018 | 15 | 0.060 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 37 | 0.050 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2002 | 11 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 221 | 0.050 |
Why?
|
Mental Disorders | 2 | 2013 | 96 | 0.050 |
Why?
|
Disease Progression | 2 | 2014 | 566 | 0.040 |
Why?
|
HMGA2 Protein | 1 | 2019 | 14 | 0.040 |
Why?
|
Electromagnetic Fields | 1 | 2019 | 25 | 0.040 |
Why?
|
Movement Disorders | 1 | 2019 | 22 | 0.040 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 59 | 0.040 |
Why?
|
China | 1 | 2018 | 42 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2017 | 1059 | 0.040 |
Why?
|
Area Under Curve | 1 | 2018 | 77 | 0.040 |
Why?
|
Immunotherapy | 1 | 2019 | 65 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2019 | 92 | 0.040 |
Why?
|
Video Recording | 1 | 2018 | 51 | 0.040 |
Why?
|
ROC Curve | 1 | 2018 | 146 | 0.040 |
Why?
|
Neoplastic Stem Cells | 1 | 2019 | 88 | 0.040 |
Why?
|
Sucrose | 1 | 1998 | 7 | 0.040 |
Why?
|
Cell Line | 1 | 2019 | 418 | 0.040 |
Why?
|
Ligands | 1 | 2018 | 59 | 0.040 |
Why?
|
Quinazolines | 1 | 2018 | 30 | 0.040 |
Why?
|
Neurotic Disorders | 1 | 2017 | 1 | 0.040 |
Why?
|
Personality | 1 | 2017 | 13 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 323 | 0.040 |
Why?
|
Forecasting | 1 | 2018 | 130 | 0.040 |
Why?
|
Universities | 1 | 2018 | 137 | 0.040 |
Why?
|
Anxiety | 1 | 2018 | 132 | 0.040 |
Why?
|
Risk Factors | 2 | 2018 | 3520 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2019 | 515 | 0.040 |
Why?
|
Resilience, Psychological | 1 | 2017 | 15 | 0.040 |
Why?
|
Alcoholism | 1 | 1998 | 61 | 0.040 |
Why?
|
Autoradiography | 3 | 2003 | 34 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 659 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 206 | 0.040 |
Why?
|
tau Proteins | 1 | 2017 | 37 | 0.040 |
Why?
|
Frontal Lobe | 1 | 2016 | 35 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 165 | 0.040 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 10 | 0.040 |
Why?
|
Cerebellum | 1 | 2016 | 25 | 0.040 |
Why?
|
Genetic Association Studies | 1 | 2016 | 171 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 1998 | 198 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2016 | 71 | 0.030 |
Why?
|
Schools | 1 | 2016 | 60 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2017 | 216 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 95 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2017 | 480 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2017 | 631 | 0.030 |
Why?
|
Incidence | 1 | 2018 | 1087 | 0.030 |
Why?
|
Risk | 1 | 2016 | 290 | 0.030 |
Why?
|
Forehead | 1 | 2015 | 7 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2016 | 116 | 0.030 |
Why?
|
Edema | 1 | 2015 | 30 | 0.030 |
Why?
|
Memory | 1 | 2016 | 175 | 0.030 |
Why?
|
Stroop Test | 1 | 2014 | 6 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 22 | 0.030 |
Why?
|
Internationality | 1 | 2014 | 19 | 0.030 |
Why?
|
Neck | 1 | 2014 | 26 | 0.030 |
Why?
|
Albumins | 1 | 2014 | 38 | 0.030 |
Why?
|
Genotype | 1 | 2016 | 813 | 0.030 |
Why?
|
Smoking | 1 | 2017 | 389 | 0.030 |
Why?
|
Random Allocation | 1 | 2014 | 186 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2014 | 74 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 441 | 0.030 |
Why?
|
Aorta, Abdominal | 1 | 2013 | 29 | 0.030 |
Why?
|
Heart Diseases | 1 | 2014 | 101 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 478 | 0.030 |
Why?
|
Spinal Cord | 1 | 2014 | 113 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 196 | 0.030 |
Why?
|
Observer Variation | 1 | 2013 | 96 | 0.030 |
Why?
|
Nitrous Oxide | 1 | 2013 | 4 | 0.030 |
Why?
|
Body Water | 1 | 2013 | 8 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 1285 | 0.030 |
Why?
|
Subtraction Technique | 1 | 2013 | 12 | 0.030 |
Why?
|
Brain Death | 1 | 2013 | 24 | 0.030 |
Why?
|
Swine | 1 | 2013 | 198 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2012 | 27 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2017 | 480 | 0.030 |
Why?
|
Occipital Bone | 1 | 2012 | 13 | 0.030 |
Why?
|
Receptors, Cannabinoid | 2 | 2003 | 11 | 0.030 |
Why?
|
Sample Size | 1 | 2012 | 37 | 0.030 |
Why?
|
Air Bags | 1 | 2012 | 14 | 0.030 |
Why?
|
Neoplasms | 1 | 2019 | 596 | 0.030 |
Why?
|
Seizures | 1 | 2013 | 47 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2012 | 52 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2012 | 114 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 653 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2013 | 161 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 84 | 0.030 |
Why?
|
Glioma | 1 | 2013 | 114 | 0.030 |
Why?
|
Blood Pressure | 1 | 2016 | 861 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2013 | 694 | 0.030 |
Why?
|
Self Administration | 2 | 2003 | 66 | 0.030 |
Why?
|
Sex Factors | 1 | 2013 | 619 | 0.020 |
Why?
|
Prognosis | 1 | 2014 | 1342 | 0.020 |
Why?
|
Dementia | 1 | 2013 | 231 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2013 | 379 | 0.020 |
Why?
|
Hamartoma | 1 | 2009 | 11 | 0.020 |
Why?
|
Astrocytoma | 1 | 2009 | 25 | 0.020 |
Why?
|
Contrast Media | 1 | 2009 | 123 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 2008 | 32 | 0.020 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2008 | 7 | 0.020 |
Why?
|
Dominance, Cerebral | 1 | 2008 | 11 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2008 | 80 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2008 | 32 | 0.020 |
Why?
|
Heart Arrest | 1 | 2008 | 39 | 0.020 |
Why?
|
Homeostasis | 1 | 2008 | 140 | 0.020 |
Why?
|
Glycolysis | 1 | 2003 | 19 | 0.010 |
Why?
|
Drug Tolerance | 1 | 2003 | 17 | 0.010 |
Why?
|
Conditioning, Operant | 1 | 2003 | 20 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2003 | 135 | 0.010 |
Why?
|
Neocortex | 1 | 1998 | 4 | 0.010 |
Why?
|
Limbic System | 1 | 1998 | 8 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1998 | 53 | 0.010 |
Why?
|
Injections | 1 | 1998 | 61 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1998 | 73 | 0.010 |
Why?
|
Administration, Oral | 1 | 1998 | 163 | 0.010 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 1998 | 2 | 0.010 |
Why?
|